Research analysts have, from time to time, published material commenting on Clinigen.

Any opinions, estimates or forecasts regarding the Company's performance made by such analysts are theirs alone and do not represent opinions, forecasts or predictions of the Company or its Management. You should, therefore, not place undue reliance on the content of any such analyst report or statement. The following analysts currently issue reports on us:

Company Analyst
N+1 Singer Chris Glasper

Numis

Stefan Hamill

Peel Hunt

Tom Burt
RBC Nick Keher
Stifel Max Herrmann

 

These reports cannot be obtained directly from us.